 |
mobilized perioheral blood cells that have undergone ex-vivo negative functionial selection of GvHD-causing T-cells by short term incubation with Fas-ligand |
|---|---|
| Trade Name | |
| Orphan Indication | Graft Versus Host Disease |
| USA Market Approval | USA |
| USA Designation Date | 2017-08-15 00:00:00 |
| Sponsor | Cellect Biotherapeutics;23 Ha'Taas Street, P.O. Box 2442;Kfar Saba |
